Cosmetic neurology
The controversy over enhancing movement, mentation, and mood
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Advances in cognitive neuroscience and neuropharmacology are yielding exciting treatments for neurologic diseases. Many of these treatments are also likely to have uses for people without disease. Here, I review the ways in which medicine might make bodies and brains function better by modulating motor, cognitive, and affective systems. These potential “quality of life” interventions raise ethical concerns, some related to the individual and others related to society. Despite these concerns, I argue that major restraints on the development of cosmetic neurology are not likely. Neurologists and other clinicians are likely to encounter patient-consumers who view physicians as gatekeepers in their own pursuit of happiness.
- Received January 8, 2004.
- Accepted in final form May 3, 2004.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Reply to Letter to the Editor
- Stephen Hauser, University of California SF, 505 Parnassus Ave San Francisco, CA 94143hauser@neurology.ucsf.edu
Submitted February 21, 2005 - Neuroenhanced Soldiers - A further response
- Richard H. Dees, MD, University of Rochester, 601 Elmwood Ave., Rochester, NY 14642richard_dees@urmc.rochester.edu
Submitted January 21, 2005 - Reply to Russo et al
- Anjan Chatterjee, University of Pennsylvania, 3 West Gates, 3400 Spruce St. Philadelphiaanjan@mail.med.upenn.edu
Submitted January 21, 2005 - Cosmetic neurology: The controversy over enhancing movement, mentation, and mood
- Leiutenant Colonel Michael Russo, MD, US Army Aeromedical Research Laboratory, michael.russo@us.army.mil
- COL Cornelius Maher, M.D., COL William Campbell, M.D
Submitted January 21, 2005
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David Beversdorf and Dr. Ryan Townley
► Watch
Related Articles
Alert Me
Recommended articles
-
Article
Degree of serotonin reuptake inhibition of antidepressants and ischemic riskA cohort studyAntonios Douros, Sophie Dell'Aniello, Golsa Dehghan et al.Neurology, August 07, 2019 -
Articles
High insulinlike growth factor I is associated with cognitive decline in Huntington diseaseN. Saleh, S. Moutereau, J.-P. Azulay et al.Neurology, July 05, 2010 -
Articles
SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhageA. B. Singhal, M. A. Topcuoglu, D. J. Dorer et al.Neurology, March 21, 2005 -
Views and Reviews
Rethinking the thinking capEthics of neural enhancement using noninvasive brain stimulationRoy Hamilton, Samuel Messing, Anjan Chatterjee et al.Neurology, January 10, 2011